https://apcac.edu.in/

https://zygpharma.com/

https://blognonian.com/

https://www.veniceroyalmaids.com/

https://www.darbarsaheb.com/

https://activacert.com/

https://persebaya88.com/

https://vernwilliams.com/

https://livetv102.net/

https://synfreeware.com/

https://intersoftscripts.com/

https://scriptsonweb.com/

https://masterresalerightsempire.com/

https://vidpart.com/

https://hothitdownload.com/

https://topdownloads360.com/

https://labradoraccounting.com/

https://adutils.com/

https://nowgoal288.net/

http://63.250.38.239/

https://www.google.co.id/search?q=leon288

https://www.google.com/?q=leon288

https://www.google.com/search?q=slot+gacor+leon288

https://www.google.com/search?q=slot+online+gacor+leon288

Torrent Pharmaceuticals

Investors

Investors > FY 2019-20

Investors > FY 2019-20



1. Annual Report

Intimation for Presentation to analysts on audited financial result for the quarter and year ended 31st March, 2020
Intimation for Concall with Investor / Analysts Q4_2019-20
Intimation of Board Meeting dated 26-May-20
Shareholding pattern Q4
Declaration of Interim Dividend and pay out date
Intimation of Record Date
Intimation of the Board Meeting dated 11-03-2020
Intimation for Trading Window Closure
Cancellation of the record date
Newspaper Advertisement of financial result for Q3_2019-20
Intimation for change in directorate
Intimation under Regulation 30_BM dated 27-01-2020
Intimation for Presentation to analysts on audited Financial Results for the quarter and nine months ended 31st December, 2019
Intimation for Concall with Investor/Analysts Q3 2019-20
Shareholding Pattern Q3
Intimation of the Record date
Newspaper Advertisement of BM Notice_27-01-2020
Intimation of the Board Meeting dated 27-01-2020
Payment of Interest & Partial Redemption of Secured Redeemable Non-Convertible Debenture issued under ISIN: INE685A07074
Payment of Interest & Partial Redemption of Secured Redeemable Non-Convertible Debenture issued under ISIN:INE685A07066 & INE685A07082
Name Change of RTA
Newspaper advertisement in respect of the transfer of shares to IEPF(2012-13 Interim)
Compliance as per Regulation 23(9) Of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for half year ended 30th September 2019
Clarification regarding pledge of shares by promoters
Intimation for presentation to analyst on audited financial result for quarter ended 30th September, 2019
Intimation for Concall with Investor / Analysts Q2 2019-20 - Revised
Shareholding Pattern Q2
Intimation for Concall with Investor / Analysts Q2 2019-20
Newspaper advertisement of BM notice – 23-10-2019
Intimation of the Board Meeting dated 23-Oct-19
Disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015
Intimation for Trading Window Closure
Disclosure by Torrent Pvt. Ltd. (on behalf of all promoters) in its capacity as Promoter of Torrent Pharmaceuticals Ltd.
Intimation regarding issue of Non-Convertible Debenture on private placement basis
Intimation of Redemption of Commercial Papers
Intimation of Credit Rating for the proposed issue of NCDs
Public Notice – 21st August,2019
USFDA classifies inspection at Indrad facility as OAI
Newspaper Advertisement of Financial Result for Q1 2019-20
Intimation for presentation to analyst on audited financial result for quarter ended 30th June, 2019
Change in Directorate
Shareholding Pattern Q1
USFDA classifies inspection at Dahej facility as OAI
Intimation for Concall with Investor/Analysts Q1 2019-20
Press Release - Glenmark & Torrent sign licensing agreement for co-marketing of Remogliflozin Etabonate in India
Newspaper Advertisement of BM Notice-23-7-2019
Intimation of the Board Meeting dated 23-July-19
Intimation for Trading Window closure
Redemption of Non-Convertible Debentures(NCDs)_ INE685A07033
Payment of Interest_ INE685A07033 and INE685A07041 & Redemption of Secured Redeemable Non-Convertible Debenture (NCDs)_ INE685A07033
Intimation Regarding Issue of Commercial Papers
Intimation Regarding Redemption of Commercial Papers
Intimation Regarding Issue of Commercial Papers
Intimation regarding USFDA audit at Indrad Plant in April 2019
Intimation regarding USFDA audit at Dahej Plant in March 2019
Intimation of the Closure of Trading Window dated 04.04.2019
Intimation of Cessation of Director of the Company

Details of Nodal Officer

Name : Chintan Trivedi

Designation : Company Secretary

E-mail Id : investorservices@torrentpharma.com

IEPF Authority - Refund web page

IEPF Authority - Refund web page >>